Compare GIC & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIC | CMPS |
|---|---|---|
| Founded | 1949 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | 2020 |
| Metric | GIC | CMPS |
|---|---|---|
| Price | $28.60 | $11.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $25.38 |
| AVG Volume (30 Days) | 68.6K | ★ 5.7M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 17.09 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $1,379,100,000.00 | N/A |
| Revenue This Year | $5.72 | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | $68.02 | ★ N/A |
| Revenue Growth | ★ 4.80 | N/A |
| 52 Week Low | $25.62 | $2.25 |
| 52 Week High | $38.53 | $11.08 |
| Indicator | GIC | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 34.26 | 70.33 |
| Support Level | $26.51 | $5.95 |
| Resistance Level | $34.57 | N/A |
| Average True Range (ATR) | 1.15 | 0.64 |
| MACD | -0.49 | 0.10 |
| Stochastic Oscillator | 15.48 | 94.44 |
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw material.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.